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Abstract
Background—Chlamydia pneumoniae illness is poorly characterized, particularly as a sole 
causative pathogen. We investigated a C. pneumoniae outbreak at a federal correctional facility.
Methods—We identified inmates with acute respiratory illness (ARI) from 1 November 2009 to 
24 February 2010 through clinic self-referral and active case finding. We tested oropharyngeal 
and/or nasopharyngeal swabs for C. pneumoniae by real-time polymerase chain reaction (qPCR) 
and serum samples by microimmunofluorescence. Cases were inmates with ARI and 
radiologically confirmed pneumonia, positive qPCR, or serological evidence of recent infection. 
Swabs from 7 acutely ill inmates were tested for 18 respiratory pathogens using qPCR TaqMan 
Array Cards (TACs). Follow-up swabs from case patients were collected for up to 8 weeks.
Results—Among 33 self-referred and 226 randomly selected inmates, 52 (20.1%) met the case 
definition; pneumonia was confirmed in 4 by radiology only, in 9 by qPCR only, in 17 by serology 
only, and in 22 by both qPCR and serology. The prison attack rate was 10.4% (95% confidence 
interval, 7.0%–13.8%). White inmates and residents of housing unit Y were at highest risk. TAC 
testing detected C. pneumoniae in 4 (57%) inmates; no other causative pathogens were identified. 
Among 40 inmates followed prospectively, C. pneumoniae was detected for up to 8 weeks. 
Thirteen (52%) of 25 inmates treated with azithromycin continued to be qPCR positive >2 weeks 
after treatment.
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Conclusions—Chlamydia pneumoniae was the causative pathogen of this outbreak. Higher risk 
among certain groups suggests that social interaction contributed to transmission. Persistence of C. 
pneumoniae in the oropharynx creates challenges for outbreak control measures.
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Chlamydia (Chlamydophila) pneumoniae is an obligate intracellular bacterium commonly 
associated with both upper and lower respiratory tract infections including pharyngitis, 
bronchitis, and pneumonia. First described in 1986, C. pneumoniae infections generally 
consist of low-grade fever, prolonged cough, coryza, headache, myalgias, and laryngitis [1, 
2]. Macrolides are a common first-line treatment; however, tetracyclines and fluoro-
quinolones are also effective. Symptoms may resolve without antibiotics and asymptomatic 
infection can occur [3–5].
Chlamydia pneumoniae is endemic world-wide. Outbreaks occur periodically and without a 
clear seasonal pattern, primarily in close-contact settings among high-risk populations such 
as in long-term care facilities [6–8]. Chlamydia pneumoniae is frequently detected alongside 
other respiratory pathogens, making its role as a primary disease-causing pathogen unclear 
[9–11]. The diagnosis of C. pneumoniae infection is commonly made through commercially 
available serological assays, despite poor sensitivity and specificity due to high background 
seroprevalence and potential cross-reaction with other Chlamydia species [12]. More 
recently, real-time polymerase chain reaction (qPCR) assays are being used to identify C. 
pneumoniae from respiratory specimens that are highly sensitive and specific for acute C. 
pneumoniae infection but are unable to provide a retrospective diagnosis [13–15].
During November 2009–February 2010, an outbreak of pneumonia was identified in a male 
federal correctional institution in Texas. Symptoms included low-grade fever, dry cough, 
and body aches, and illness appeared to occur in previously healthy inmates. Four inmates 
were hospitalized. Sputum and blood cultures, sputum testing for acid-fast bacilli, and urine 
testing for Legionella and Histoplasma were negative. This report describes the outbreak’s 
laboratory and epidemiological investigation, and illustrates the challenges of implementing 
outbreak control interventions in this setting.
METHODS
Outbreak Setting and Pathogen Identification
The facility’s 1574 inmates resided in 2 housing units, each with 3 floors. Although housing 
units were racially mixed, inmates comingled along ethnic (or gang) lines in common areas. 
Healthcare services were available for a nominal fee and smoking was not permitted on the 
premises. Upon suspicion of the outbreak, ill inmates were placed in single-celled housing 
units until their symptoms improved. Nasopharyngeal (NP) and oropharyngeal (OP) 
specimens available from 7 acutely ill inmates were sent to the Centers for Disease Control 
and Prevention (CDC) for multiple respiratory pathogen testing to rapidly identify the 
etiology.
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Case Finding and Estimation of Attack Rate
We reviewed available prison medical records on 33 of 36 inmates who had self-referred to 
the facility’s infirmary during the outbreak period (1 November 2009–24 February 2010) 
and had been diagnosed with suspected or confirmed pneumonia. To establish a facility-
wide attack rate and identify C. pneumoniae infection among inmates who did not seek 
medical care, we conducted active case finding among a systematic random sample of 
inmates. The sample size was calculated based on an expected maximum attack rate of 20% 
and 10% refusal rate; 270 beds were selected (17.5% of the inmate population). Beds were 
selected from a list of all bed numbers at the facility (minus known pneumonia cases) sorted 
by building, floor, and bunk (upper or lower).
Consenting inmates, both randomly selected and self-referred, were interviewed using a 
standardized questionnaire to collect demographic and clinical information, details on 
housing assignments, and general activities within the prison. Race categories were assigned 
by the Federal Bureau of Prisons (BOP). Information on past medical history was obtained 
via inmate report, prison records, and BOP’s electronic medical records. Inmates provided 
NP and OP, or combined NP/OP, swabs, except in cases where collection of 1 type of swab 
(NP or OP) was refused. Acute and convalescent sera for C. pneumoniae–specific serologies 
(immunoglobulins M [IgM] and G [IgG]) were collected from consenting participants who 
were symptomatic during the interview or who had experienced an acute respiratory 
infection within the previous month.
Case Definitions
We defined a case of C. pneumoniae illness as acute respiratory illness (ARI) in an inmate 
residing within the facility during the outbreak period supported by either radiological 
confirmation of pneumonia (noted by 2 independent readers) or laboratory evidence of acute 
C. pneumoniae infection. ARI was defined as myalgias, headache, or sore throat in the 
presence of cough lasting ≥3 days, self-reported fever ≥99°F, or self-reported chills. 
Laboratory evidence of acute infection was defined as C. pneumoniae detected by qPCR 
(from NP, OP, or NP/OP swab), an IgM titer of ≥1:10, or a ≥4-fold increase in IgG antibody 
titer between paired sera obtained 3–6 weeks apart. Persons with laboratory evidence of 
acute C. pneumoniae infection without ARI were defined as asymptomatic cases.
Risk Factor Analyses
To identify known risk factors for C. pneumoniae infection, we conducted 2 independent 
analyses using (1) self-referred cases, and (2) randomly selected cases. Persons identified in 
the systematic random sample who were not identified as cases and had neither an ARI nor 
laboratory evidence of infection served as controls; persons reporting an ARI without 
laboratory evidence of infection were excluded from these analyses.
Study of Persistence of C. pneumoniae After Infection
We tracked C. pneumoniae in the oropharynx after infection by weekly follow-up OP swabs 
among cases. During each swab collection, inmates reported current symptoms and 
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antibiotics usage within the preceding 7 days. Participants were followed for up to 8 weeks, 
until they had ≥2 consecutive negative samples, or until they declined participation.
Laboratory Analysis
The initial 7 NP/OP swabs from acutely ill inmates were tested using qPCR at the CDC’s 
Respiratory Diseases Branch Laboratory in Atlanta, Georgia, using the TaqMan Array Card 
(TAC) for influenza (A and B), respiratory syncytial virus, human parainfluenza virus (types 
1, 2, and 3), human metapneumovirus, rhinovirus, enterovirus, human parechovirus, 
adenovirus, Legionella pneumophila, Haemophilus influenzae, Streptococcus pneumoniae, 
Streptococcus pyogenes, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Bordetella 
pertussis. Subsequent testing of respiratory and serological specimens was performed at the 
CDC using methods that have been previously described [15]. In brief, all NP and OP 
specimens were collected using Dacron swabs and immediately placed in refrigerated 
universal transport media (Becton Dickinson, Franklin Lakes, New Jersey). Serum samples 
and swabs were frozen at −20°C within 12 hours and sent to the CDC for analysis. Swabs 
were tested using a real-time multiplex PCR assay for detection of C. pneumoniae, M. 
pneumoniae, Legionella species, and a human DNA internal control [16]. Acute and 
convalescent sera were tested for C. pneumoniae–specific IgM and IgG antibodies using 
commercially available microimmunofluorescence kits (FOCUS Diagnostics, Cypress, 
California).
Statistical Analysis
Data were analyzed using SAS software, version 9.2 (SAS Institute, Cary, North Carolina). 
Weighted attack rates were calculated using the proportion of inmates represented by the 
sample. A suspected pneumonia attack rate was calculated for cases who self-referred for 
care and was added to the weighted sample attack rate to estimate the facility-wide attack 
rate. The variance of the estimated facility-wide attack rate included the variance of the 
weighted sample attack rate and the self-referred cases’ attack rate. Odds ratios and 95% 
confidence intervals comparing self-referred cases to randomly selected controls were 
calculated from univariate logistic regression models. Relative risks and 95% confidence 
intervals comparing randomly selected cases to randomly selected controls were calculated 
from univariate log binomial models.
RESULTS
Descriptive Epidemiology of the Outbreak
Of 36 inmates who self-referred for care during the outbreak, 3 did not meet case criteria. 
Among the remaining 33, 15 (45.5%) had radiologically confirmed pneumonia and 29 
(87.9%) had laboratory confirmation of C. pneumoniae infection. Clinical characteristics 
were incomplete for 6 (Table 1), including 3 who refused to participate in the survey. 
Among 270 beds randomly selected for active case finding, 254 were occupied at the time of 
the survey; of these, 223 (87.8%) inmates consented to participate. The random sample 
identified 19 additional cases, bringing the total number to 52.
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Inmates who self-referred for care were older (median age, 42 years) than cases identified by 
the systematic random sample (median age, 35 years; Table 1). Self-referred cases were also 
more often white (55.6%) or African American (33.3%), or lived in housing unit Y (69.7%). 
In contrast, random sample cases were more frequently Hispanic (26.3%) or reported a 
history of asthma (26.3%). The most common symptoms among cases were cough ≥3 days 
(98.0%), runny nose (72.9%), and sore throat (72.9%). The median duration of cough at 
time of case detection was 21 days (range, 1–64). In general, symptoms were reported more 
frequently among cases who self-referred compared to those identified through random 
selection.
Forty-eight cases had laboratory confirmation of C. pneumoniae infection; 29 (60.4%) self-
referred for care. Among the 15 self-referred cases with radiologically confirmed 
pneumonia, 9 (60%) tested positive by qPCR for C. pneumoniae. Eight (42.1%) cases 
identified by random selection had a qPCR-positive swab, 14 (87.5%) had elevated IgM, 
and 1 (25%) of 4 who provided paired sera demonstrated a 4-fold rise in IgG. Eight 
asymptomatic C. pneumoniae–infected inmates were identified during the survey; 1 through 
a qPCR-positive OP swab and 7 through IgM-positive serologies.
Weighted attack rates for C. pneumoniae infection ranged by floor and unit (Table 2), with a 
facility-wide attack rate of 10.4% (95% confidence interval, 7.0%–13.8%) and the highest 
attack rate on the second floor of housing unit Y (13.6%). The onset of illness among cases 
in housing unit Y generally preceded those in housing unit X (Figure 1).
Risk Factor Analysis Findings
A total of 155 inmates from the random sample were without ARI or laboratory evidence of 
C. pneumoniae infection and were identified as controls and independently compared to the 
33 self-referred and 19 randomly selected cases. Both self-referred and randomly selected 
cases were more often of white race compared to Hispanic and reside in housing unit Y, 
although these findings were statistically significant only for self-referred cases (Table 3). 
Latino-Hispanic inmates were at lowest risk of infection for self-referred cases. We found 
no associations with self-reported history of asthma, preincarceration smoking status, 
educational level, or time spent in any specific areas of the facility.
Laboratory Results
From the 7 NP/OP specimens available for TAC testing, 4 (57.1%) tested positive for C. 
pneumoniae (1 was also positive for S. pneumoniae). One each was weakly positive for S. 
pneumoniae and H. influenzae, which frequently colonize the upper respiratory tract. Results 
for all other 15 pathogens were negative. Based on these findings, C. pneumoniae was 
determined to be the sole causative pathogen in the outbreak.
Among 256 randomly sampled and self-referred inmates, we collected combined NP/OP 
swabs from 66 (25.5%), paired separate NP and OP swabs from 29 (11.2%), only NP from 1 
(0.3%), and only OP from 160 (61.8%). Positivity rates were 19.7% among combined NP/
OPs, 10% among NPs, and 3.7% among OPs. Among 29 inmates who had NP and OP 
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swabs collected and tested separately, only 2 had discrepant results; in both cases, OP swabs 
were positive and NP swabs were negative (data not shown).
Among 122 (47.1%) inmates who submitted single serum samples, 33 (12.7%) submitted 
paired serum samples 4–6 weeks later. This included 65 inmates who reported an ARI 
during the outbreak period but who were negative for C. pneumoniae infection by qPCR. Of 
these, 35 (59.3%) had a single IgG titer for C. pneumoniae ≥512 and 17 (28.8%) had a 
single IgM titer ≥10 (Table 4). Among 37 inmates with no ARI symptoms and who were 
negative by qPCR for C. pneumoniae, 23 (62.2%) had a single IgG assay and 7 (18.9%) had 
a single IgM assay showing elevated antibody levels.
Persistence of C. pneumoniae After Infection
We collected additional OP swabs on 40 inmates for up to 8 weeks after the initial 
investigation: 36 individuals met our case definition, 3 described an ARI but did not meet 
case criteria, and 1 self-referred for care after conclusion of the investigation and tested 
positive for C. pneumoniae by qPCR. For 12 (30.0%) inmates, no C. pneumoniae was 
detected at any visit (Figure 2). Among 28 inmates who tested qPCR positive for C. 
pneumoniae at least once, 6 were positive only on 1 swab; 22 others were positive up to 8 
weeks after the outbreak investigation (median, 5 weeks). Sixteen (57.1%) received 
antibiotic treatment >2 weeks prior to their positive swab (13 with azithromycin; 3 with 
nonspecified antibiotic). A positive qPCR test was associated with cough in 35 of 69 
(50.1%) carriage episodes. Six (30.0%) persons tested positive by qPCR following a single 
negative swab, and 4 (10.0%) tested positive after 2 consecutive negative swabs. At the time 
of their last swab, 16 (40%) inmates were both asymptomatic and qPCR-negative.
Public Health Interventions
To stop transmission among inmates, the facility posted educational notices around the 
prison and encouraged sick inmates to present for care and early initiation of treatment by 
waiving the usual clinic fee and discontinuing single-cell housing of ill persons. A 5-day 
course of azithromycin was recommended for persons presenting with signs and symptoms 
of C. pneumoniae infection; a 14-day course of doxycycline was recommended for those 
who remained symptomatic after completing azithromycin. The last confirmed C. 
pneumoniae case was detected on 3 March 2010, 9 days after the outbreak investigation 
concluded; demographic and clinical data were not available for this inmate.
DISCUSSION
This report summarizes the largest C. pneumoniae outbreak confirmed by qPCR. The long 
duration of the outbreak (over 4 months) is consistent with C. pneumoniae outbreaks 
described in military barracks [17, 18] and contrasts with the shorter duration (1–2 months) 
often seen in long-term care facilities [6, 7]. The attack rates seen in this prison were lower 
than the median reported among long-term care facilities (46%), possibly due to lower 
prevalence of comorbid conditions as this facility was rated care level 2 by the BOP, and 
inmates did not have medical conditions that required more than routine appointments for 
monitoring [8]. The clinical presentation and spectrum of illness parallels those seen in other 
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C. pneumoniae outbreaks [11, 19], although we did not find a large number of asymptomatic 
qPCR-positive persons.
Inmates generally spent a large portion of the day together and slept on bunks spaced 
approximately 3–5 feet apart, facilitating transmission of C. pneumoniae. The increased risk 
of C. pneumoniae infection among white inmates may have been due to social interaction; 
inmates frequently congregated along racial or ethnic lines, increasing likelihood of 
transmission within.
Several studies have demonstrated an increased risk of C. pneumoniae illness, particularly 
severe disease, among the elderly and persons with asthma or chronic obstructive pulmonary 
disease (COPD) [7, 11, 20]. In this investigation, inmates with C. pneumoniae tended to be 
older than those who were not ill; however, this trend was not statistically significant. In 
addition, none of the 4 persons hospitalized during the outbreak were >45 years of age. We 
did not see any increased risk among persons with asthma, COPD, or other chronic medical 
conditions. The lack of association between C. pneumoniae and previously established risk 
factors may be attributed to a lack of statistical power to detect one or to the lower 
prevalence of chronic medical conditions in our inmate population than that seen at long-
term health facilities and greater variability in age than military barracks. In previous 
studies, smoking has also been associated with an earlier illness onset; however, its 
prohibition in federal prisons did not allow us to determine current smoking status for 
inmates.
Postinfection carriage of C. pneumoniae is not uncommon, and several studies have used 
culture to document persistence of the organism for up to 12 months after acute infection [2, 
21]. Although these studies were small, shedding of C. pneumoniae continued after 
completion of treatment with tetracycline or doxycycline (range, 5–31 days). Here we 
document persistence of the organism in the oropharynx by qPCR for up to 8 weeks 
following appropriate antibiotic therapy. Most participants in our follow-up study continued 
to experience cough symptoms for several weeks after their first qPCR-positive swab. 
Persistence of respiratory symptoms and C. pneumoniae detection after acute infection has 
been theorized to be due to chronic intracellular infection and sustained airway irritation 
[22]. In this outbreak, close living quarters and poor compliance with medications may have 
led to reexposure to C. pneumoniae and contributed to ongoing transmission.
Our findings may not fully represent the spectrum of C. pneumoniae illness because we 
were unable to identify all symptomatic inmates and, although qPCR is highly sensitive for 
detecting acute shedding, it was not used on cases that occurred earlier in the outbreak. We 
also utilized serological markers to identify C. pneumoniae infection, which may have cross-
reacted with other Chlamydia species, specifically C. trachomatis [14, 15, 23]. Our results 
again demonstrate problems with specificity, as several inmates without symptoms who 
were negative by qPCR nonetheless had elevated IgM antibody levels. Although IgG 
measurements in paired sera are generally more reliable, timing is essential to diagnosis. 
Here, sera collected outside the acute and convalescent phases of illness may not have 
demonstrated a 4-fold increase distinguishing recent from past exposure.
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Over the past several decades, US correctional facilities have become a congregate setting of 
increasing importance to public health. The number of incarcerated persons in US jails and 
prisons has reached historic highs, compounded by inmate overcrowding [24]. A 
disproportionate number of inmates have health problems that put them at risk for serious 
complications of respiratory infections, making the early detection and containment of 
outbreaks a priority for correctional healthcare and public health authorities [25]. Despite 
constitutional entitlement of all inmates to basic healthcare, correctional facilities present 
unique public health challenges: close quarters facilitate droplet transmission, and medical 
illness is often underreported due to fear of stigmatization or isolation. Control of respiratory 
outbreaks can be difficult because of poor compliance with recommended behavioral 
modifications (eg cough etiquette, medication compliance) and because routine respiratory 
precautions (eg masks, alcohol-based sanitizers, soap dispensers) are often not feasible in 
this setting.
Key lessons learned from this outbreak investigation include (1) diagnostic advantages of 
using qPCR to identify C. pneumoniae during respiratory outbreaks; (2) recognition that 
antibiotic therapy for C. pneumoniae may not readily reduce coughing or eliminate carriage; 
(3) importance of inmate education and elimination of medical copay to maximize case 
identification during outbreaks in the correctional setting; and (4) prioritization of hand 
hygiene as the key infection control measure in jails and prisons. Last, this investigation 
highlights the value of collaboration between public health and corrections officials to 
advance our understanding of respiratory outbreaks and their management.
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Distribution of Chlamydia pneumoniae cases by date of symptom onset and residential 
housing unit during an outbreak at a federal correctional facility (N = 52). The last 
laboratory-confirmed C. pneumoniae case was detected on 3 March 2010; however, 
symptom onset data were not available.
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Antibiotic usage and persistence of Chlamydia pneumoniae carriage and symptoms over 
time among 40 cases of C. pneumoniae respiratory infection at a federal correctional facility. 
*Indicates chest radiography–confirmed pneumonia. Abbreviations: AC, symptomatic, 
cleared (real-time polymerase chain reaction [qPCR] negative); AP, symptomatic, persistent 
infection (or reinfection); D, doxycycline; NS, not specified; SC, symptomatic, cleared 
(qPCR negative); SP, symptomatic, persistent infection (or reinfection); Z, azithromyccin.
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Table 1
Characteristics of Respiratory Illness Among Inmates Who Self-Referred for Care and Were Identified by a 









 Age, y, median (range)a 42 (22–78) 35 (24–59) 40 (22–78)
Race and ethnicity
 White 15 (45.5) 9 (47.4) 24 (46.2)
 Asian/Pacific Islander 2 (6.0) 1 (5.3) 3 (5.8)
 African American 9 (27.3) 4 (21.0) 13 (25.0)
 Hispanic 1 (3.0) 5 (26.3) 6 (11.5)
 Missing race data 6 (18.2) 0 6 (11.5)
Past medical historyb
 Current or past smoker 17 (56.7) 9 (47.4) 26 (53.1)
 Self-reported asthma diagnosis 3 (13.0) 5 (26.32) 8 (19.0)
 Any self-reported chronic illnessc 14 (42.4) 10 (52.6) 24 (46.2)
Unit of residence
 Housing unit X 10 (30.3) 11 (57.9) 21 (40.4)
 Housing unit Y 23 (69.7) 8 (42.1) 31 (59.6)
Clinical characteristics and laboratory findings
 Pulmonary infiltrate on chest radiographyb 15 (45.5) NA 15 (45.5)
 Any laboratory test positiveb 29 (87.9) 19 (100) 48 (92.3)
 PCR positive 23 (69.7) 8 (42.1) 31 (59.6)
 4-fold increase in IgGd 5 (35.7) 1 (25.0) 6 (33.3)
 Single IgM ≥10e 24 (85.7) 14 (87.5) 38 (86.4)
Symptomsb,f
 Cough 29 (96.7) 19 (100) 48 (98.0)
 Runny nose 18 (62.1) 17 (89.5) 35 (72.9)
 Sore throat 23 (79.3) 12 (63.2) 35 (72.9)
 Sputum 19 (65.5) 14 (73.7) 33 (68.8)
 Fever or chills 25 (86.2) 7 (38.9) 32 (68.1)
 Shortness of breath 24 (82.8) 4 (21.1) 28 (58.3)
 Wheezing 21 (72.4) 6 (35.3) 27 (58.7)
 Headache 18 (60.0) 4 (21.1) 22 (44.9)
 Sinus pain/pressure 11 (44.0) 8 (42.1) 19 (43.2)
 Joint or muscle aches 14 (48.3) 4 (21.1) 18 (37.5)
 Ear pain/pressure 6 (23.1) 2 (10.5) 8 (17.8)
 Diarrhea 6 (20.7) 0 6 (12.5)





















 Vomiting 3 (10.3) 1 (5.3) 4 (8.3)
 Median duration of cough, d 29 (1–64) 7 (3–42) 21 (1–64)
Abbreviations: IgG, immunoglobulin G; IgM, immunoglobulin M; NA, not applicable, none of the randomly selected inmates had x-rays taken; 
PCR, polymerase chain reaction.
a
Data missing for 1 participant.
b
Cases with missing data were excluded from these figures.
c
Includes diabetes, asthma, chronic obstructive pulmonary disease, chronic liver disease, hypercholesterolemia, human immunodeficiency virus 
infection, obesity, atherosclerosis, and heart failure.
d
Convalescent sera were available from 14 self-presenting cases and 4 surveyed cases.
e
Acute sera were available from 28 self-presenting cases and 16 surveyed cases.
f
Clinical symptoms obtained from the questionnaire were not available for 3 self-referred inmates; partial data were available for 4 self-referred 
inmates who completed a pilot questionnaire.
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Table 2
Weighted Attack Rates of Chlamydia pneumoniae Infection Among 1574 Inmates in a Federal Correctional 
Facility by Housing Location
Housing Location Weighted Attack Rate (95% CI)
Facility-wide 10.4 (7.0–13.8)
Housing unit X (all floors) 10.0 (5.3–14.7)
 Floor 1 4.8 (0–12.0)
 Floor 2 9.7 (2.2–17.3)
 Floor 3 12.8 (4.6–21.0)
Housing unit Y (all floors) 10.9 (5.9–15.8)
 Floor 1 0.8 (0–2.2)
 Floor 2 13.6 (4.3–23.0)
 Floor 3 12.5 (5.0–20.0)
Abbreviation: CI, confidence interval.
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Table 4
Agreement of Antibody Testing With Real-Time Polymerase Chain Reaction Results During an Outbreak of 
Chlamydia pneumoniae in a Federal Correctional Facility, Among Samples From Inmates With and Without 
Acute Respiratory Illnessa
C. pneumoniae qPCR Result Single IgM ≥1:10 Single IgG ≥1:512 4-Fold Increase in IgG
No ARI
 qPCR-positive (n = 1) 0/1 (0%) 1/1 (100%) 0/0
 qPCR-negative (n = 37) 7/37 (18.9%) 23/37 (62.2%) 0/1 (0%)
ARI
 qPCR-positive (n = 25) 21/25 (84.0%) 24/25 (96.0%) 4/10 (40.0%)
 qPCR-negative (n = 59) 17/59 (28.8%) 35/59 (59.3%) 2/22 (9.1%)
Results shown are the number positive/number tested (%).
Abbreviations: ARI, acute respiratory illness; IgG, immunoglobulin G; IgM, immunoglobulin M; qPCR, real-time polymerase chain reaction.
a
ARI defined as follows: cough lasting ≥3 days AND 1 or more of the following: myalgias, headache, sore throat; OR fever ≥37.2°C or chills AND 
1 or more of the following: myalgias, headache, sore throat, cough ≥3 days.
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